Summit Therapeutics Net Tangible Assets

As of the most recent data (June 2026), SMMT shows a net tangible assets of $630M. That compares with $260M in the prior-year period — up 142.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SMMT's net tangible assets is now $630M (was $260M) — a 142.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Summit Therapeutics is outperforming or lagging.

Tracking SMMT's net tangible assets over time shows whether Summit Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $630M That compares with $260M in the prior-year period — up 142.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Summit Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $630M) with ownership activity and broader fundamentals.